136 related articles for article (PubMed ID: 18029081)
1. Structural interpretation of reduced insulin activity as seen in the crystal structure of human Arg-insulin.
Sreekanth R; Pattabhi V; Rajan SS
Biochimie; 2008 Mar; 90(3):467-73. PubMed ID: 18029081
[TBL] [Abstract][Full Text] [Related]
2. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
[TBL] [Abstract][Full Text] [Related]
3. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of insulin NPH formulations.
Norrman M; Hubálek F; Schluckebier G
Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
[TBL] [Abstract][Full Text] [Related]
6. A structural switch in a mutant insulin exposes key residues for receptor binding.
Ludvigsen S; Olsen HB; Kaarsholm NC
J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695
[TBL] [Abstract][Full Text] [Related]
7. Metal induced structural changes observed in hexameric insulin.
Sreekanth R; Pattabhi V; Rajan SS
Int J Biol Macromol; 2009 Jan; 44(1):29-36. PubMed ID: 18977386
[TBL] [Abstract][Full Text] [Related]
8. 1.42A crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure.
Yun CH; Tang YH; Feng YM; An XM; Chang WR; Liang DC
Biochem Biophys Res Commun; 2005 Jan; 326(1):52-9. PubMed ID: 15567151
[TBL] [Abstract][Full Text] [Related]
9. Receptor binding redefined by a structural switch in a mutant human insulin.
Hua QX; Shoelson SE; Kochoyan M; Weiss MA
Nature; 1991 Nov; 354(6350):238-41. PubMed ID: 1961250
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a prolonged-acting insulin with albumin-binding properties.
Whittingham JL; Havelund S; Jonassen I
Biochemistry; 1997 Mar; 36(10):2826-31. PubMed ID: 9062110
[TBL] [Abstract][Full Text] [Related]
11. Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
Weiss MA; Wan Z; Zhao M; Chu YC; Nakagawa SH; Burke GT; Jia W; Hellmich R; Katsoyannis PG
J Mol Biol; 2002 Jan; 315(2):103-11. PubMed ID: 11779231
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.
Wan Z; Xu B; Huang K; Chu YC; Li B; Nakagawa SH; Qu Y; Hu SQ; Katsoyannis PG; Weiss MA
Biochemistry; 2004 Dec; 43(51):16119-33. PubMed ID: 15610006
[TBL] [Abstract][Full Text] [Related]
13. The relationship between insulin bioactivity and structure in the NH2-terminal A-chain helix.
Olsen HB; Ludvigsen S; Kaarsholm NC
J Mol Biol; 1998 Nov; 284(2):477-88. PubMed ID: 9813131
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the T-->R transition of insulin by helix-promoting sequence modifications at the N-terminal B-chain.
Shneine J; Voswinkel M; Federwisch M; Wollmer A
Biol Chem; 2000 Feb; 381(2):127-33. PubMed ID: 10746744
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of ultralente--a microcrystalline insulin suspension.
Wagner A; Diez J; Schulze-Briese C; Schluckebier G
Proteins; 2009 Mar; 74(4):1018-27. PubMed ID: 18767151
[TBL] [Abstract][Full Text] [Related]
17. NMR structure of biosynthetic engineered human insulin monomer B31(Lys)-B32(Arg) in water/acetonitrile solution. Comparison with the solution structure of native human insulin monomer.
Bocian W; Borowicz P; Mikołajczyk J; Sitkowski J; Tarnowska A; Bednarek E; Głabski T; Tejchman-Małecka B; Bogiel M; Kozerski L
Biopolymers; 2008 Oct; 89(10):820-30. PubMed ID: 18491415
[TBL] [Abstract][Full Text] [Related]
18. Changes in secondary structure follow the dissociation of human insulin hexamers: a circular dichroism study.
Melberg SG; Johnson WC
Proteins; 1990; 8(3):280-6. PubMed ID: 2281088
[TBL] [Abstract][Full Text] [Related]
19. Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal.
Gao Y; Wang Y
Biochemistry; 2006 Dec; 45(51):15654-60. PubMed ID: 17176087
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of opsin in its G-protein-interacting conformation.
Scheerer P; Park JH; Hildebrand PW; Kim YJ; Krauss N; Choe HW; Hofmann KP; Ernst OP
Nature; 2008 Sep; 455(7212):497-502. PubMed ID: 18818650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
